Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
1 competing product in clinical development for Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ME-401 | Kyowa Kirin | Phase 1 | Completed | 29 |